Placeholder product photography for this preview build — final vial imagery and label artwork to be supplied by the client.
Retatrutide
10 mg / 20 mg / 30 mg · Lyophilized powder · SKU WV-RETA-10
A 39-residue peptide that agonises three receptors at once — GLP-1, GIP and glucagon. The most complex agonist in the catalogue.
Compound information
Retatrutide is a single-molecule triple agonist, active at the GLP-1, GIP and glucagon receptors. Adding glucagon receptor activity is what separates it from the dual agonists: glucagon signalling raises energy expenditure while the incretin arms suppress intake, so the three inputs are studied as an interacting system rather than as three independent effects.
Research context
- Triple receptor binding, potency and balance across GLP-1R, GIPR and GCGR
- Energy expenditure versus intake suppression
- Hepatic glucose output and lipid handling
- Comparative studies against dual and single agonists
Reconstitution & handling
Allow the vial to reach room temperature before opening. Reconstitute with bacteriostatic water introduced slowly against the vial wall — do not inject directly onto the lyophilized cake and do not shake.
- Store lyophilized at −20 °C, protected from light.
- Store reconstituted solution at 2–8 °C and use within the study window.
- Avoid repeated freeze–thaw cycles.
- Handle under standard laboratory practice with appropriate PPE.
Shipping & documentation
Orders are dispatched same-day when placed before 14:00 local time. Compounds ship lyophilized and are shelf-stable in transit; packaging is discreet and tamper-evident with tracking on every order.
A lot-specific Certificate of Analysis is issued for every batch and is available from the lab results library.